Table 1.

Demographic, clinical, epidemiological and analytical data of patients with CDI.

Number of hospitalization	N = 130 (N=24a, N=106b)
Admission (N = 130)	N, %
from home	85; 65.4%
another ward or hospital	27; 20.8%
nursing home/senior care facility	10; 7.7%
from a hospice	1; 0.8%
no data	7; 5.4%
Previous hospitalizationc	111; 85.40%
Previous surgical proceduresc	57; 43.8%
Length of hospitalizationd	13 days; [IQR: 8–27]
Time from hospital admission to stool sample collectiond	4 days [IQR: 1–14]
Comorbidities (N = 118*)	N; %
hypertension	70; 59.3%
coronary artery disease/ heart failure	63; 53.4%
atherosclerosis	51; 43.2%
diabetes	47; 39.8%
C. difficile-associated colitis and enteritis	4; 3.4%
Analytical Datae
creatinine [mg/dL]	1.4 ± 1.17
WBC [×109/L]	14.033 ± 12.231
albuminf [g/L]	24.07 ± 8.67
Previous use of antibiotics	N; %
use	92; 70.8%
cephalosporines	38; 41.3%
fluoroquinolones	18; 19.6%
penicillins with beta- lactamase inhibitors	13; 14.1%
no antibiotics	6; 4.6%
no data	32; 24.6%
Antibiotic used for CDI treatment	N; %
use	80; 61.5%
vancomycin	55; 68.75%
metronidazole	10; 12.5%
both antibiotics	15; 18.75%
no data	50; 38.5%
Hospital discharge (N = 130)	N; %
home	94; 72.3%
another ward/ healthcare facility	16; 12.3%
death	18; 13.8%
no data	2; 1.54%

*patients with obtained medical history, re-hospitalized patients were counted only once.

^aSecondary care hospital.

^bTertiary care hospital.

^cDuring a 12-week period.

^dMedian and interquartile range.

^eMeans ± standard deviation.

^fAlbumin was measured in only 34 patients.